

Is Tenofovir Alafenamide (Vemlidy) in shortage in 2026? Get the latest update on availability, cost, and what hepatitis B patients can do right now.
If you take Tenofovir Alafenamide (brand name Vemlidy) for chronic hepatitis B, you may have heard conflicting information about whether it's in shortage. Maybe your pharmacy couldn't fill your prescription, or you've seen mentions of supply issues online. Let's cut through the noise and give you a clear picture of what's happening with Tenofovir Alafenamide availability in 2026.
As of early 2026, Vemlidy (Tenofovir Alafenamide) is not listed on the FDA's official drug shortage database as a standalone product. However, that doesn't tell the whole story.
Many patients are reporting difficulty finding Vemlidy at their local pharmacies. This isn't necessarily a manufacturing shortage — it's more of an availability and access problem. The reality is that many pharmacies simply don't stock Vemlidy routinely because it's a high-cost specialty medication with a relatively small patient base.
Additionally, some TAF-containing HIV combination products like Biktarvy and Descovy have experienced periodic supply constraints, which can create uncertainty across the broader TAF supply chain.
Several factors are contributing to the difficulty patients face when trying to fill their Vemlidy prescriptions:
Despite FDA approval for generic manufacture, no generic Tenofovir Alafenamide is currently marketed in the United States. A generic combination product (Emtricitabine/TAF) was authorized in the European Union in 2025, but this hasn't translated to US availability yet. Without generic competition, supply remains limited to Gilead's brand product.
Vemlidy costs approximately $1,500 to $1,800 per month without insurance. Many retail pharmacies, especially chains, don't keep expensive specialty medications on their shelves unless they have regular customers who need them. This means your pharmacy might need to special-order it, which can take several days.
Some insurance plans require patients to use specialty pharmacies or mail-order services for Vemlidy, rather than retail pharmacies. If your prescription is sent to a pharmacy that isn't in your plan's specialty network, it may appear as if the drug is "unavailable" when the issue is actually an insurance routing problem.
Understanding the cost picture can help you navigate your options:
For detailed savings strategies, read our complete guide on how to save money on Tenofovir Alafenamide.
While the landscape for hepatitis B treatment hasn't seen a dramatic shift recently, there are a few developments worth noting:
Here are your best options for locating Vemlidy right now:
For a detailed walkthrough, see our post on how to find Tenofovir Alafenamide in stock near you.
Tenofovir Alafenamide isn't in a formal FDA-declared shortage, but real-world access challenges mean many patients are struggling to get their prescriptions filled. The combination of high cost, no US generic, and limited pharmacy stocking creates a frustrating situation for people who depend on this medication.
Stay proactive: use tools like Medfinder, explore financial assistance programs, and keep your doctor informed about any access issues. Your hepatitis B treatment is essential, and there are paths to keeping it on track.
For more information about this medication, explore our guides on what Tenofovir Alafenamide is, side effects to watch for, and drug interactions to avoid.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.